Added to YB: 2025-07-30
Pitch date: 2025-07-28
ERF.PA [neutral]
Eurofins Scientific SE
-11.94%
current return
Author Info
D Invests is a self taught investor with a focus on quality and value. This newsletter focuses on businesses within their portfolio past and present. Their aim is to double their investments every 5 years resulting in a target 15% CAGR. Sign up for the newsletter.
Company Info
Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide.
Market Cap
EUR 10.0B
Pitch Price
EUR 65.50
Price Target
N/A
Dividend
1.06%
EV/EBITDA
8.43
P/E
28.59
EV/Sales
1.88
Sector
Life Sciences Tools and Services
Category
growth
Eurofins 1H 2025 update.
ERF.PA (earnings update): H1 2025 revenue +5.7% (3.9% organic) to €3.6B, EBITDA +8% to €773M (21.4% margin), EPS +18% to €1.20. Strategic investment phase (IT, owned sites) temporarily depressing FCF but building competitive advantage. 22 acquisitions at 0.75x sales. Smart buybacks at depressed prices. Full moat benefits expected post-2027 investment phase.
Read full article (4 min)